{
  "docId": "019de077-4649-72e2-aa45-017392de211d",
  "docSlug": "8a7a8508ae9537047e1aabcda9819db4",
  "documentTitle": "NeuroSense Therapeutics | Investor Presentation Deck | 27 slides",
  "authorId": "neurosense-therapeutics",
  "authorName": "NeuroSense Therapeutics",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2024-10-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 23,
  "pageCount": 27,
  "prevPage": 22,
  "nextPage": 24,
  "slideType": "appendix_methodology",
  "function": "plan_implementation",
  "density": "balanced",
  "nDataPoints": 4,
  "notes": "The slide uses a process-oriented visual to outline the study parameters and the three key focus areas (Safety, Efficacy, Biomarkers).",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de077-4649-72e2-aa45-017392de211d/23",
  "deckHref": "/decks/019de077-4649-72e2-aa45-017392de211d",
  "deckJsonHref": "/decks/019de077-4649-72e2-aa45-017392de211d.json",
  "deckAnchorHref": "/decks/019de077-4649-72e2-aa45-017392de211d#slide-23",
  "components": [
    {
      "bbox": {
        "h": 0.5,
        "w": 0.65,
        "x": 0.31,
        "y": 0.33
      },
      "kind": "diagram",
      "text": "Primary Endpoint Safety & Tolerability; Secondary Efficacy Clinical Outcomes; Target Engagement Biomarkers",
      "attrs": null,
      "subkind": "process",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "cc9be826-b247-478d-b6e4-323ff2258884",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.25,
        "x": 0.05,
        "y": 0.475
      },
      "kind": "list",
      "text": "20 patients with mild to moderate AD\n1:1 PrimeC to Placebo\n12-month dosing\nClinic visit every 3 months\nSingle-center",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "0f84763a-c4cb-4866-a644-adc083588844",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.045,
        "w": 0.763,
        "x": 0.076,
        "y": 0.145
      },
      "kind": "title",
      "text": "Randomized, Prospective, Double-Blind, Placebo-Controlled Study",
      "attrs": null,
      "subkind": "action-title",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "40dd5b42-6bb3-47f7-81a9-fceb42ba30e9",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.045,
        "w": 0.415,
        "x": 0.076,
        "y": 0.085
      },
      "kind": "title",
      "text": "RoAD Phase 2 Study Design",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c1881d18-b85b-440d-9247-427d193e92a5",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "clinical-trial-design",
      "slug": null,
      "matchId": "3a5c3170-32b0-4826-b4d8-566397d03e2f",
      "evidence": "Standardized representation of study parameters and endpoints",
      "confidence": 0.8
    }
  ],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}